Home › Funds › Carmignac Gestion › REGN

Carmignac Gestion position in REGN

REGENERON PHARMACEUTICALS · Health Care

Carmignac Gestion reported holding 182,987 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$138.7M, representing 2.21% of its reported portfolio and ranking #14 among its reported holdings. Carmignac Gestion has disclosed REGN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)182.99K sh
Reported value held$138.73M
Portfolio Weight2.21%
First reportedQ4 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Carmignac Gestion's REGN position evolved

Carmignac Gestion first disclosed a stake in REGN in Q4 2025 at 49,971 shares (US$38.6M). The position peaked in Q3 2026 at 182,987 shares, worth US$138.7M. Across 4 filings, Carmignac Gestion increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 182,987 shares valued at US$138.7M. Notable position changes include a 133% increase in Q1 2026 (shares fell 18% over the following quarter), a 57% increase in Q2 2026 (shares rose 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 49.97K $38.58M New
Q1 2026 116.57K $90.01M Add
Q2 2026 182.51K $113.83M Add
Q3 2026 182.99K $138.73M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Carmignac Gestion held REGN?

Carmignac Gestion has disclosed REGN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Carmignac Gestion's current position in REGN?

As of Q3 2026, Carmignac Gestion holds 182.99K shares of REGN (REGENERON PHARMACEUTICALS), valued at $138.73M, representing 2.21% of its reported portfolio and ranking #14.

Has Carmignac Gestion been buying or selling REGN?

In the latest 13F filing (Q3 2026), Carmignac Gestion held unchanged its position in REGN. The position peaked in Q3 2026 at 182.99K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.